Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products- Real-World Analysis in Japan
Abstract
Authors
T Karumori A Chhabra J Alvir PF Fogarty D Spurden BJ Tortella E Rubinstein A Pleil